More on Monsanto's (MON) FQ1 results: Seeds and genomics sales rose 14% to $1.8B, with corn seed...

|About: Monsanto Company (MON)|By:, SA News Editor

More on Monsanto's (MON) FQ1 results: Seeds and genomics sales rose 14% to $1.8B, with corn seed and traits net sales up 27% Y/Y to $1.1B, driven by strength in Brazil, Argentina and Mexico. Raises FY13 EPS guidance to $4.30-$4.40 vs. prior $4.18-$4.32 and $4.40 consensus. Raises FY13 free cash flow guidance to $1.8B-$2B. Shares look headed to new 52-week highs, +4.7% premarket.